The Future is in Focus: Nurturing Innovation and Collaboration in Pediatric Liver Transplantation

Poster Session
Welcome Reception & Poster Session
View Poster Presenters & Abstracts

Thursday April 23, 2026 | 17:45 to 19:45
Room: FOYER
Track: N/A

Presentations

Jennifer Lau, United States
Patient and family perspectives on lifelong biliary atresia care

Dr. Sagar Mehta, Canada
Outcomes and recurrence patterns after curative surgery for advanced hepatoblastoma

Dr. Tierra L Mosher, United States
Cost-Effectiveness of Adolescent-Initiated Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Modeled Implications for Long-Term Liver Transplantation Risk

Dr. Tyler J York, United States
Initial Experience with Post-Operative Contrast Enhanced Ultrasound Following Pediatric Whole and Partial Deceased Donor Liver Transplant

Dr. Ane M Andres, Spain
Hypothermic oxygenated perfusion: Standard of care in pediatric liver transplantation

Dr. Kyla P McDonald, Canada
Early Insights from PeLTQL Integration: A QI Snapshot in Pediatric Liver Transplantation

Dr. Ioannis A. Ziogas, United States
Impact of Donor Age and Graft Type on Outcomes After Pediatric Liver Transplantation for Biliary Atresia

David Lee, United States
Successful outcomes with ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression protocols with selective use of desensitization therapy

Dr. Alyshah Lakhani, United States
Genetic Testing Strategies for Neonatal Cholestasis and Markers associated with Diagnostic Testing in the NICU

Alaa Abdelghani, United States
Sustained Immunosuppression Minimization After Pediatric Liver Transplantation: Outcomes Through 10 Years

Lindsay J Aschliman, United States
Evaluation of a Pediatric-to-Adult Liver Transplant Transition Education Program: A Quality Improvement Pilot

Mr. Joshua Badshah, United States
Stability-Selected Machine Learning Identifies Key Determinants of Early Graft Failure in Pediatric Liver Transplantation

Dr. Ali B Abbasi, United States
The impact of early mortality on the survival benefit of pediatric liver transplantation

Dr. David O Walls, United States
DCD-NRP a valid approach to increase pediatric donation: first report of a combined liver-pancreas transplant

Dr. Stephen Philip Dunn, United States
Pediatric simultaneous liver-kidney transplant: A 25-year single center experience

Wendy Sevilla, United States
BOLD and BOLD-EXT, the first global phase III clinical program to evaluate the long-term efficacy and safety of odevixibat in infants with biliary atresia after Kasai hepatoportoenterostomy – study design and current status

Dr. Ashritha Avalareddy, India
The PRO-KASAI Study: Primary vs Rescue Liver Transplant Outcomes in Children With Biliary Atresia (BA) After Kasai Portoenterostomy (KPE) – Analysis of the Indian Liver Transplant Registry

Ms. Leanna Shea, United States
Indirect Calorimetry in Children with Chronic Liver Disease Awaiting Liver Transplant

Dr. Annadiletta Donà, Italy
Portal vein thrombosis prevention and cure in pediatric liver transplantation: a comprehensive strategy

Dr. Forum Patel, United States
Terlipressin therapy for portal hyperperfusion secondary to portal vein size discrepancy after pediatric liver transplant

Nawras Habash, United States
Neonatal Cholestasis with Bile Duct Paucity in a Patient with a de novo EP300 Pathogenic Variant

Dr. Brynna H Blanchet PhD, United States
From Screening to Support: Implementation of Caregiver Distress Assessment in Pediatric Liver Transplant

Dr. Neslihan Çelik, Turkey
Pediatric liver paired exchange transplantation as a lifesaving procedure under emergency conditions

Dr. James Reed, United States
Veno-occlusive disease after chimeric antigen receptor T-cell therapy

Dr. Blake Rosenthal, United States
Quality improvement project: age-based order set for diagnostic evaluation of pediatric patients presenting in acute Liver failure

Ahmad Salah Sami, United States
Tacrolimus: Old drug, new tricks to reduce early acute T cell-mediated rejection rates in pediatric liver transplant recipients

Dr. Diana C Altamirano Montealvo, Mexico
Implementation of a pediatric living donor liver transplantation program in a tertiary care hospital in a developing country

Dr. Anna I Barclay, United States
A Standardized Guidance Document for Pediatric Liver Transplantation in People with Advanced Cystic Fibrosis-Related Liver Disease

Amrita Narang, United States
Feeding the flame, one day at a time: design of a serious game to support medication adherence and education for pediatric liver transplant patients

Dr. Kathryn Czepiel MD MS, United States
Reasons for deferral and denial in living donor candidates: a single-center exploratory study

Dr. Kathryn Czepiel MD MS, United States
Marked muscle wasting in pediatric liver transplant registrants: a retrospective cohort analysis using OPTN data

Mr. Samson W Wong, United States
Project Hope: a peer support network for pediatric, adolescent, and young adult solid organ transplant recipients

Dr. Amber Gafur, United States
Social Determinants of Health in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease: Utilizing the Childhood Opportunity Index (COI)

Amala J Alenchery MD, United States
Role of Biologic Therapies in Chronic Allograft Enteropathy in Pediatric Intestinal/Multivisceral Transplantation: A Single Center Experience

Dr. Maria F Nieves Arreola, Mexico
Survival and waitlist mortality in pediatric liver transplantation: a comparative analysis of biliary atresia vs. chronic liver diseases in Mexico

Dr. Ane M Andres, Spain
Auxiliary split-hope liver transplantation from a donation after circulatory death donor as treatment for pediatric acute liver failure: case report

Simone Santoro Angelo Zaragoza, United States
Selection, Timing, and Outcomes of Pediatric Liver Transplantation for Malignant Liver Tumors

Dr. Samantha Kanterman, United States
EPHB4-related capillary malformation-arteriovenous malformation (CM-AVM) syndrome due to hepatic arteriovenous malformation: a case report

Dr. Arielle Melen, United States
Management of Severe Pediatric Tacrolimus Overdose With Intravenous Fluids and Fosphenytoin-Induced Enzyme Induction: A Case Report

Prof. Maren Schulze, Germany
Hypothermic oxygenated machine perfusion (HOPE) of a partial split liver graft for acute liver failure following amatoxin poisoning.

The WebApp is sponsored by:

Organized by

A section of

Sponsored by

Email: info@splitmeeting.org
If you have any questions during the meeting, please go to the registration desk. Our emails will be monitored sporadically.

REGISTRATION DESK OPENING TIMES

Wednesday, April 22, 12pm-1pm
Thursday, April 23, 6:15am-6:15pm
Friday, April 24, 6:45am-4:30pm
© 2026 SPLIT 2026